Importance of gene expression signatures in pancreatic cancer prognosis and the establishment of a prediction model

References

• KamisawaTWoodLDItoiTTakaoriKPancreatic cancerLancet201638810039738526830752
   PubMed Web of Science ®Google Scholar
• AppelBLTolatPEvansDBTsaiSCurrent staging systems for pancreatic cancerCancer J201218653954923187840
   PubMed Web of Science ®Google Scholar
• WijnhovenBPTranKTEstermanAWatsonDITilanusHWAn evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagusAnn Surg2007245571772517457164
   PubMed Web of Science ®Google Scholar
• OshimaMOkanoKMurakiSImmunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancerAnn Surg2013258233634623470568
   PubMed Web of Science ®Google Scholar
• KongFLiLWangGDengXLiZKongXVDR signaling inhibits cancer-associated-fibroblasts’ release of exosomal miR-10a-5p and limits their supportive effects on pancreatic cancer cellsGut2018
   Web of Science ®Google Scholar
• GiboriHEliyahuSKrivitskyAAmphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancerNat Commun2018911629295989
   PubMedGoogle Scholar
• MelloSSValenteLJRajNA p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic CancerCancer Cell201732446047329017057
   PubMed Web of Science ®Google Scholar
• ChiouSHRiscaVIWangGXBLIMP1 Induces transient metastatic heterogeneity in pancreatic cancerCancer Discov20177101184119928790031
   PubMed Web of Science ®Google Scholar
• WartenbergMCibinSZlobecIIntegrated genomic and immunophenotypic classification of pancreatic cancer reveals three distinct subtypes with prognostic/predictive significanceClin Cancer Res201824184444445429661773
   PubMed Web of Science ®Google Scholar
• ZhangDLiLJiangHConstitutive IRAK4 activation underlies poor prognosis and chemoresistance in pancreatic ductal adenocarcinomaClin Cancer Res20172371748175927702822
   PubMed Web of Science ®Google Scholar
• GuoKCuiJQuanMThe novel KLF4/MSI2 signaling pathway regulates growth and metastasis of pancreatic cancerClin Cancer Res201723368769627449499
   PubMed Web of Science ®Google Scholar
• AlizadehAAEisenMBDavisREDistinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature2000403676950351110676951
   PubMed Web of Science ®Google Scholar
• PerouCMSørlieTEisenMBMolecular portraits of human breast tumoursNature2000406679774775210963602
   PubMed Web of Science ®Google Scholar
• McdermottUDowningJRStrattonMRGenomics and the continuum of cancer careNew Engl J Med2011364434035021268726
   PubMed Web of Science ®Google Scholar
• SongJXuQZhangHFive key lncRNAs considered as prognostic targets for predicting pancreatic ductal adenocarcinomaJ Cell Biochem201811964559456929239017
   PubMed Web of Science ®Google Scholar
• ShiXHLiXZhangHA five-microRNA signature for survival prognosis in pancreatic adenocarcinoma based on TCGA dataSci Rep201881763829769534
   PubMedGoogle Scholar
• TusherVGTibshiraniRChuGSignificance analysis of microarrays applied to the ionizing radiation responseProc Natl Acad Sci U S A20019895116512111309499
   PubMed Web of Science ®Google Scholar
• Huitzil-MelendezFDCapanuMO’ReillyEMAdvanced hepatocellular carcinoma: which staging systems best predict prognosis?J Clin Oncol201028172889289520458042
   PubMed Web of Science ®Google Scholar
• BleyTAKotterESaueressigUUsing receiver operating characteristic methodology to evaluate the diagnostic quality of radiography on paper prints versus filmAJR Am J Roentgenol200318161487149014627560
   PubMed Web of Science ®Google Scholar
• HuangJLFuYPJingCYA novel and validated prognostic nomogram based on liver fibrosis and tumor burden for patients with hepatocellular carcinoma after curative resectionJ Surg Oncol2018117462563329165812
   PubMed Web of Science ®Google Scholar
• WuJZhouLHuangLNomogram integrating gene expression signatures with clinicopathological features to predict survival in operable NSCLC: a pooled analysis of 2164 patientsJ Exp Clin Cancer Res2017361428057025
   PubMedGoogle Scholar
• ItoKMurphyDApplication of ggplot2 to pharmacometric graphicsCPT Pharmacometrics Syst Pharmacol20132e7924132163
   PubMedGoogle Scholar
• MooreHEAndlauerOSimonNMignotEExploring medical diagnostic performance using interactive, multi-parameter sourced receiver operating characteristic scatter plotsComput Biol Med20144712012924561350
   PubMed Web of Science ®Google Scholar
• Je˛droszkaDOrzechowskaMHamouzRGórniakKBednarekAKMarkers of epithelial-to-mesenchymal transition reflect tumor biology according to patient age and Gleason score in prostate cancerPLoS One20171212e018884229206234
   PubMed Web of Science ®Google Scholar
• Moreno-BetancurMSadaouiHPiffarettiCReyGSurvival analysis with multiple causes of death: extending the competing risks modelEpidemiology2017281121927362647
   PubMed Web of Science ®Google Scholar
• MillerMEHuiSLTierneyWMValidation techniques for logistic regression modelsStat Med1991108121312261925153
   PubMed Web of Science ®Google Scholar
• MaJSawaiHMatsuoYIGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cellsJ Surg Res201016019010119560785
   PubMed Web of Science ®Google Scholar
• RoySKSrivastavaRKShankarSInhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancerJ Mol Signal201051020642839
   PubMedGoogle Scholar
• WeiWTChenHWangZHEnhanced antitumor efficacy of gemcitabine by evodiamine on pancreatic cancer via regulating PI3K/Akt pathwayInt J Biol Sci20128111422211100
   PubMed Web of Science ®Google Scholar
• AwasthiNYenPLSchwarzMASchwarzREThe efficacy of a novel, dual PI3K/mTOR inhibitor NVP-BEZ235 to enhance chemotherapy and antiangiogenic response in pancreatic cancerJ Cell Biochem2012113378479122020918
   PubMed Web of Science ®Google Scholar
• ZhangSLiuQLiuYQiaoHLiuYZerumbone, a southeast Asian ginger sesquiterpene, induced apoptosis of pancreatic carcinoma cells through p53 signaling pathwayEvid Based Complement Alternat Med2012201218
   Web of Science ®Google Scholar
• LiLYueGGLauCBEriocalyxin B induces apoptosis and cell cycle arrest in pancreatic adenocarcinoma cells through caspase- and p53-dependent pathwaysToxicol Appl Pharmacol20122621809022561874
   PubMed Web of Science ®Google Scholar
• HastieECataldiMSteuerwaldNGrdzelishviliVZAn unexpected inhibition of antiviral signaling by virus-encoded tumor suppressor p53 in pancreatic cancer cellsVirology201548312614025965802
   PubMed Web of Science ®Google Scholar
• WuZChoHHamptonGMTheodorescuDCdc6 and cyclin E2 are PTEN-regulated genes associated with human prostate cancer metastasisNeoplasia2009111667619107233
   PubMed Web of Science ®Google Scholar
• ChenSChenXXieGCdc6 contributes to cisplatin-resistance by activation of ATR-Chk1 pathway in bladder cancer cellsOncotarget2016726403624037627246979
   PubMed Web of Science ®Google Scholar
• MahadevappaRNevesHYuenSMThe prognostic significance of Cdc6 and Cdt1 in breast cancerSci Rep20177198528428557
   PubMed Web of Science ®Google Scholar
• DengYJiangLWangYHigh expression of CDC6 is associated with accelerated cell proliferation and poor prognosis of epithelial ovarian cancerPathol Res Pract2016212423924626920249
   PubMed Web of Science ®Google Scholar
• BorladoLRMéndezJCDC6: from DNA replication to cell cycle checkpoints and oncogenesisCarcinogenesis200829223724318048387
   PubMed Web of Science ®Google Scholar
• ChenCHLinDSChengCWCdc6 cooperates with c-Myc to promote genome instability and epithelial to mesenchymal transition EMT in zebrafishOncotarget20145156300631125051368
   PubMedGoogle Scholar
• FengLBarnhartJRSeegerRCCdc6 knockdown inhibits human neuroblastoma cell proliferationMol Cell Biochem20083111–218919718259842
   PubMed Web of Science ®Google Scholar
• BarghashAHelmsVKesslerSMOverexpression of IGF2 mRNA-binding protein 2 (IMP2/p62) as a feature of basal-like breast cancer correlates with short survivalScand J Immunol201582214214325916626
   PubMed Web of Science ®Google Scholar
• BarghashAGolob-SchwarzlNHelmsVHaybaeckJKesslerSMElevated expression of the IGF2 mRNA binding protein 2 (IGF2BP2/IMP2) is linked to short survival and metastasis in esophageal adenocarcinomaOncotarget2016731497434975027391348
   PubMedGoogle Scholar
• KesslerSMLaggaiSBarghashAIMP2/p62 induces genomic instability and an aggressive hepatocellular carcinoma phenotypeCell Death Dis20156e189426426686
   PubMed Web of Science ®Google Scholar
• LiuWLiZXuWWangQYangSHumoral autoimmune response to IGF2 mRNA-binding protein (IMP2/p62) and its tissue-specific expression in colon cancerScand J Immunol201377425526023421499
   PubMed Web of Science ®Google Scholar
• HuangRSZhengYLLiCDingCXuCZhaoJMicroRNA-485-5p suppresses growth and metastasis in non-small cell lung cancer cells by targeting IGF2BP2Life Sci201819910411129510198
   PubMed Web of Science ®Google Scholar
• YeSSongWXuXZhaoXYangLIGF2BP2 promotes colorectal cancer cell proliferation and survival through interfering with RAF-1 degradation by miR-195FEBS Lett2016590111641165027153315
   PubMed Web of Science ®Google Scholar
• ZhuCLiuYQChenFKHuDLYuZBQianLMLYRM1, a gene that promotes proliferation and inhibits apoptosis during heart developmentMolecules201015106974698220938407
   PubMed Web of Science ®Google Scholar
• NaqviNLiMYahiroEGrahamRMHusainAInsights into the characteristics of mammalian cardiomyocyte terminal differentiation shown through the study of mice with a dysfunctional c-kitPediatr Cardiol200930565165819165540
   PubMed Web of Science ®Google Scholar
• ChanGKJablonskiSAStarrDAGoldbergMLYenTJHuman Zw10 and ROD are mitotic checkpoint proteins that bind to kinetochoresNat Cell Biol200021294494711146660
   PubMed Web of Science ®Google Scholar